Enkai Cell Technology

Shanghai, China · Founded 2020 · Privately Held (backing)

Researcher of immune cell drugs designed for tumour patients. Enkai Cell Technology is based in Shanghai, China and was founded in 2020. It has raised $28.9 million.

Last price · $/share
—
Implied valuation
—
Total raised
$28.9M
Last round
—

Who backs Enkai Cell Technology?

11 investors
InvestorType
The Chinese Academy of Sciences Venture Capital ManagementOther
Yijin CapitalOther
3Sbio—
Beijing FOF Capital—
Chengyi Capital (Nanjing)—
Gandao Investment Holding Company—
Harbour BioMed—
Huagai Capital—
Qiaojing Capital—
Sirius Capital—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Enkai Cell Technology investors

11 investors are on record for Enkai Cell Technology, including The Chinese Academy of Sciences Venture Capital Management, Yijin Capital, 3Sbio and Beijing FOF Capital.

Free account
More of Enkai Cell Technology with a free account
  • ·The complete investor list: 11 names
  • ·Watch Enkai Cell Technology: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like Enkai Cell Technology. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View